This website uses cookies to enhance the user experience.
21st logo
||
TA

Terje Arnulf Johansen1955

Shareholdings
4
Arrow
14
Double arrow
Norway Business roles
15

Roles

Management

NameRoleTotal operating incomeTotal equityShares
F
FDV TROMS AS
Managing Director/CEO
7,782,689
1,198,813
60.79 %
indirectly
L
LYR INVEST AS
Managing Director/CEO
-
-
60.79 %
directly
T
TAJ HOLDING AS
Managing Director/CEO
7,615,775
244,122,694
60.79 %
indirectly
A
ARELIA AS
Managing Director/CEO
-
-51,238
48.63 %
indirectly

Boards

NameRoleTotal operating incomeTotal equityShares
C
CAMPUS NORGE AS
Chairman
1,989,120
1,000,000
60.79 %
indirectly
F
FDV TROMS AS
Chairman
7,782,689
1,198,813
60.79 %
indirectly
L
LYR INVEST AS
Chairman
-
-
60.79 %
directly
T
TAJ EIENDOM AS
Under liquidation
Chairman
-
974,477
60.79 %
indirectly
B
BOLIGUTVIKLING SØR AS
Under liquidation
Chairman
-
508,870
60.79 %
indirectly
T
TAJ HOLDING AS
Chairman
7,615,775
244,122,694
60.79 %
indirectly
A
ALPINBYEN AS
Chairman
-
11,316,128
60.79 %
indirectly
A
ARELIA AS
Chairman
-
-51,238
48.63 %
indirectly
A
ANS BYGG I NORD
Closed
Participant with Joint and Several Liability (Full Responsibility)
-
-
-
Last update: Jul 22, 2025

Shares owned by Terje Arnulf Johansen

NameShare classTotal operating incomeTotal equityShare
A
AKER ASA
Ordinære aksjer
0
18,422,000,000
< 0.01 %
directly
L
LYR INVEST AS
B-aksjer
A-aksjer
0
0
0
0
25.9 %
directly 60.79 %
34.89 %
directly 60.79 %
C
CAMPUS NORGE AS
1,989,120
1,000,000
60.79 %
indirectly
F
FDV TROMS AS
7,782,689
1,198,813
60.79 %
indirectly
T
TAJ EIENDOM AS
Under liquidation
0
974,477
60.79 %
indirectly
B
BOLIGUTVIKLING SØR AS
Under liquidation
0
508,870
60.79 %
indirectly
T
TAJ HOLDING AS
7,615,775
244,122,694
60.79 %
indirectly
A
ALPINBYEN AS
0
11,316,128
60.79 %
indirectly
T
TJ EIENDOM AS
0
13,405,260
57.75 %
indirectly
A
ARELIA AS
0
-51,238
48.63 %
indirectly
0
2,014,290
18.24 %
indirectly
P
PHARMA HOLDINGS AS
2,889,281
14,055,041
6.86 %
indirectly
P
PEPTIDE PATENTS AS
778,907
617,496
6.8 %
indirectly
A
AMICOAT AS
4,139,375
9,270,321
6.74 %
indirectly
P
PHARMASUM THERAPEUTICS AS
0
0
1.28 %
indirectly
K
0
0
1.14 %
indirectly
L
LYTIX BIOPHARMA ASA
Ordinære aksjer
0
61,750,000
0.15 %
directly 0.15 %
indirectly 6.18 %

Limited to direct ownership positions of 0.5% or more.

Last update: Oct 30, 2026